UB Paderborn / Katalog / Suche / in CDI

1 – 16 von 16

Sortiert nach

Quabodepistat in combination with delamanid and bedaquiline in participants with drug-susceptible pulmonary tuberculosis: protocol for a multicenter, phase 2b/c, open-label, randomized, dose-finding trial to evaluate safety and efficacy

Trials, 2024-01, Vol.25 (1), p.70-70, Article 70

2024

Link zum Volltext

Verfügbarkeit prüfen

Compassionate use of delamanid in combination with bedaquiline for the treatment of multidrug-resistant tuberculosis

The European respiratory journal, 2019-01, Vol.53 (1), p.1801154

2019

Link zum Volltext

Verfügbarkeit prüfen

Early outcomes in MDR-TB and XDR-TB patients treated with delamanid under compassionate use

The European respiratory journal, 2017-07, Vol.50 (1), p.1700311-1700311

2017

Link zum Volltext

Verfügbarkeit prüfen

Delamanid: From discovery to its use for pulmonary multidrug-resistant tuberculosis (MDR-TB)

Tuberculosis (Edinburgh, Scotland), 2018-07, Vol.111, p.20-30

2018

Link zum Volltext

Verfügbarkeit prüfen

Compassionate use of delamanid in adults and children for drug-resistant tuberculosis: 5-year update

The European respiratory journal, 2021-05, Vol.57 (5), p.2002483

2021

Link zum Volltext

Verfügbarkeit prüfen

Population Pharmacokinetic and Concentration-QTc Analysis of Delamanid in Pediatric Participants with Multidrug-Resistant Tuberculosis

Antimicrobial agents and chemotherapy, 2022-02, Vol.66 (2), p.e0160821

2022

Link zum Volltext

Verfügbarkeit prüfen

Phase I Single Ascending Dose and Food Effect Study in Healthy Adults and Phase I/IIa Multiple Ascending Dose Study in Patients with Pulmonary Tuberculosis to Assess Pharmacokinetics, Bactericidal Activity, Tolerability, and Safety of OPC-167832

Antimicrobial agents and chemotherapy, 2023-06, Vol.67 (6), p.e0147722-e0147722

2023

Link zum Volltext

Verfügbarkeit prüfen

Delamanid Added to an Optimized Background Regimen in Children with Multidrug-Resistant Tuberculosis: Results of a Phase I/II Clinical Trial

Antimicrobial agents and chemotherapy, 2022-05, Vol.66 (5), p.e0214421-e0214421

2022

Link zum Volltext

Verfügbarkeit prüfen

Cumulative Fraction of Response for Once- and Twice-Daily Delamanid in Patients with Pulmonary Multidrug-Resistant Tuberculosis

Antimicrobial agents and chemotherapy, 2020-12, Vol.65 (1)

2020

Link zum Volltext

Verfügbarkeit prüfen

Delamanid and QT prolongation in the treatment of multidrug-resistant tuberculosis

The international journal of tuberculosis and lung disease, 2015-10, Vol.19 (10), p.1261-1262

2015

Link zum Volltext

Verfügbarkeit prüfen

Infections in lung transplantation: new insights

Current opinion in organ transplantation, 2009-10, Vol.14 (5), p.483-487

2009

Link zum Volltext

Verfügbarkeit prüfen

Incidence and Risk Factors for Incomplete HBV DNA Suppression in HIV/HBV-Coinfected Patients Initiating Tenofovir-Based Therapy

Journal of viral hepatitis, 2013-07, Vol.21 (4), p.288-296

2013

Link zum Volltext

Verfügbarkeit prüfen

Sa1966 A Comparison of the Clinical and Immunological Characteristics in Patients With Acute Hepatitis C With and Without HIV-Coinfection

Gastroenterology (New York, N.Y. 1943), 2012-05, Vol.142 (5), p.S-968-S-968

2012

Link zum Volltext

Verfügbarkeit prüfen

Drug-Resistant Tuberculosis in Sub-Saharan Africa

Current infectious disease reports, 2010, Vol.12 (1), p.36-45

2010

Link zum Volltext

Verfügbarkeit prüfen

Population pharmacokinetic rationale for intravenous contezolid acefosamil followed by oral contezolid dosage regimens

Antimicrobial agents and chemotherapy, 2024-04, Vol.68 (4), p.e0140023

2024

Link zum Volltext

Verfügbarkeit prüfen

1 – 16 von 16

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(15)
Mit Volltextzugriff
(15)

Publikationsform

Artikel
(16)

Sprache

Englisch
(16)

Erscheinungsjahr

n.n

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Quabodepistat in combination with delamanid and bedaquiline in participants with drug-susceptible pulmonary tuberculosis: protocol for a multicenter, phase 2b/c, open-label, randomized, dose-finding trial to evaluate safety and efficacy

Compassionate use of delamanid in combination with bedaquiline for the treatment of multidrug-resistant tuberculosis

Early outcomes in MDR-TB and XDR-TB patients treated with delamanid under compassionate use

Delamanid: From discovery to its use for pulmonary multidrug-resistant tuberculosis (MDR-TB)

Compassionate use of delamanid in adults and children for drug-resistant tuberculosis: 5-year update

Population Pharmacokinetic and Concentration-QTc Analysis of Delamanid in Pediatric Participants with Multidrug-Resistant Tuberculosis

Efficacy and safety of delamanid in combination with an optimised background regimen for treatment of multidrug-resistant tuberculosis: a multicentre, randomised, double-blind, placebo-controlled, parallel group phase 3 trial

Phase I Single Ascending Dose and Food Effect Study in Healthy Adults and Phase I/IIa Multiple Ascending Dose Study in Patients with Pulmonary Tuberculosis to Assess Pharmacokinetics, Bactericidal Activity, Tolerability, and Safety of OPC-167832

Delamanid Added to an Optimized Background Regimen in Children with Multidrug-Resistant Tuberculosis: Results of a Phase I/II Clinical Trial

Cumulative Fraction of Response for Once- and Twice-Daily Delamanid in Patients with Pulmonary Multidrug-Resistant Tuberculosis

Delamanid and QT prolongation in the treatment of multidrug-resistant tuberculosis

Infections in lung transplantation: new insights

Incidence and Risk Factors for Incomplete HBV DNA Suppression in HIV/HBV-Coinfected Patients Initiating Tenofovir-Based Therapy

Sa1966 A Comparison of the Clinical and Immunological Characteristics in Patients With Acute Hepatitis C With and Without HIV-Coinfection

Drug-Resistant Tuberculosis in Sub-Saharan Africa

Population pharmacokinetic rationale for intravenous contezolid acefosamil followed by oral contezolid dosage regimens

Suchergebnisse filtern